home / stock / cere / cere news


CERE News and Press, Ceres Inc.

Stock Information

Company Name: Ceres Inc.
Stock Symbol: CERE
Market: NASDAQ
Website: ceres.org

Menu

CERE CERE Quote CERE Short CERE News CERE Articles CERE Message Board
Get CERE Alerts

News, Short Squeeze, Breakout and More Instantly...

CERE - Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting

2024-06-27 13:40:30 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal Cerevel Therapeutics seesaws amid FTC notice on closed door meeting Seeking Alpha...

CERE - Tempur Sealy seesaws amid FTC notice for closed door meeting

2024-06-26 12:07:34 ET More on Tempur Sealy Tempur Sealy: Bedding Premiumization Offset By Headwinds In U.S. Mattress Market Tempur Sealy International, Inc. (TPX) Q1 2024 Earnings Call Transcript Tempur Sealy drops amid report of meeting with FTC on Mattress Firm; d...

CERE - Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal

2024-06-25 15:11:25 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics seesaws amid FTC notice on closed door meeting Cerevel Therapeutics gains after AbbVie says making good progress with FTC Seeking Al...

CERE - (CERE) Pivots Trading Plans and Risk Controls

2024-06-20 12:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CERE - Cerevel Therapeutics seesaws amid FTC notice on closed door meeting

2024-06-13 13:54:33 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics gains after AbbVie says making good progress with FTC AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug ...

CERE - Cerevel Therapeutics gains after AbbVie says making good progress with FTC

2024-06-12 11:30:31 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug Seeking Alpha’s Quant Rating on Cerevel Therapeutics Historical ear...

CERE - Tracking Baker Brothers Portfolio - Q1 2024 Update

2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...

CERE - Catalyst Watch: Apple's WWDC, Tesla's annual meeting, Fed's dot plot, and GameStop volatility

2024-06-07 15:00:58 ET More on the markets Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) SPY: 2 Options To Balance Out A Highly Concentrated Index Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity Citi – ...

CERE - Cerevel Therapeutics: Time For A Risk Arbitrage Play?

2024-06-04 04:20:17 ET Summary Cerevel Therapeutics agreed to be acquired by AbbVie on 12/06/23 for $45/s or ~$8.7B. CERE stock closed on Friday, May 31st at $40.74/s. This presents investors with a potential arbitrage play of over 10% on a deal that should close within the next 3...

CERE - Tracking George Soros's 13F Portfolio - Q1 2024 Update

2024-06-03 20:03:51 ET Summary Soros Fund Management's 13F portfolio value decreased from $7.65B to $6.02B in Q1 2024. New stakes include Cloudflare Inc. Puts, Cerevel Therapeutics, and Aramark. Stake disposals include Apple Puts, PDD Holdings Puts, and SPDR Index Euro Stocks ...

Next 10